Urinary Biomarkers as Predictors on Renal Function in Congenital Hydronephrosis
1 other identifier
observational
45
1 country
1
Brief Summary
The purpose of this study is to detect new urinary biomarkers that can be used as predictors on renal function in congenital hydronephrosis caused by unilateral ureteral obstruction (UUO) and to elucidate the pathophysiology of UUO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 5, 2007
CompletedFirst Posted
Study publicly available on registry
December 6, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedSeptember 14, 2012
September 1, 2012
4.2 years
December 5, 2007
September 13, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Urinary cytokines
1 year
Study Arms (4)
1
Children referred to surgical treatment of congenital hydronephrosis
2
15 age- and sex-matched controls
Children with healthy pelvic tissue
Children referred to nephrectomy due to nephrotic syndrome
Adults with healthy pelvic tissue
Adults referred to nephrectomy due to another cause than hydronephrosis
Eligibility Criteria
Children referred to surgical treatment of congenital hydronephrosis caused by ureteral obstruction.
You may qualify if:
- Children referred to surgical treatment of congenital hydronephrosis caused by ureteral obstruction.
- Declining function of the hydronephrotic kidney more than 5 %, and to less than 40 % of the total renal function OR ipsilateral flank pain.
You may not qualify if:
- Bilateral hydronephrosis
- Previous operation in the urinary system except operation for phimosis and other deformations of the external genital organs.
- Deformations in the lower part of the ureter, bladder and urethra. Urinary stones. Reflux. Urinary tract infections \< 6 months.
- Neurogenic bladder dysfunction.
- GFR \< 40 % standardized to age.
- Non-compliance. Linguistic difficulties.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Aarhus University Hospitalcollaborator
Study Sites (1)
Institute of Clinical Medicine, University of Aarhus
Aarhus, 8200, Denmark
Related Publications (1)
Madsen MG, Norregaard R, Palmfeldt J, Olsen LH, Frokiaer J, Jorgensen TM. Urinary NGAL, cystatin C, beta2-microglobulin, and osteopontin significance in hydronephrotic children. Pediatr Nephrol. 2012 Nov;27(11):2099-2106. doi: 10.1007/s00467-012-2217-6. Epub 2012 Jun 19.
PMID: 22710694BACKGROUND
Biospecimen
Urine and frozen pelvic tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Troels M Jørgensen, Professor, MD
Department of Urology, Aarhus University Hospital Skejby
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2007
First Posted
December 6, 2007
Study Start
November 1, 2007
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
September 14, 2012
Record last verified: 2012-09